Medartis said the acquisition of the Warsaw, Ind.-based company will allow it to expand its lower and upper extremities business in the U.S. The company’s leadership team, including CEO Rod Mayer, will stay in place, according to Medartis CEO Christoph Brönnimann.
Medartis said it will purchase Nextremities for up to $70 million, with an initial payment of $40 million upon closing of the deal, which is expected to be completed during the first half of this year.
Medartis said the first products under its ownership are expected to be launched in 2023.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
